Search company, investor...
EVOTEQ company logo


Founded Year



EVOTEQ is a UAE-based solutions provider that champions technological innovations and digital transformation across the region. It invests applications and platforms, to deliver effective, impactful and sustainable transformation of services, business performances and communities. It is based in Dubai, United Arab Emirates.

Headquarters Location

P.O Box 381000 Boulevard Plaza tower 2, office 804


United Arab Emirates

Missing: EVOTEQ's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: EVOTEQ's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest EVOTEQ News

EVOTEQ enters into a partnership agreement with Movilitas

May 3, 2021

EVOTEQ has revealed the signing of a new strategic partnership agreement with Movilitas. The partnership brings SmartTrack to the UAE and the region, a revolutionary track and trace platform that ensures product integrity in the supply chain suitable to various industries. The Ministry of Health and Prevention is pioneering the use of the technology with EVOTEQ to become the leading in the region to develop and implement ‘Tatmeen’, a digital initiative aimed at securing the management of the country’s healthcare supply chains, built on the latest technology and GS1 standards. Jihad Tayara, CEO, EVOTEQ, said, “EVOTEQ’s strategic new agreement with Movilitas is part of our efforts to bring to the region advanced technologies that could revolutionize the supply chain sector. Tatmeen as the pioneering project for the healthcare sector will showcase SmartTrack’s capabilities and importance in enhancing trust and transparency in the supply chain of various industries.” The new system will be created based on SAP solutions, utilizing SAP Advanced Track and Trace for Pharmaceuticals (ATTP) repository at the core of its operations. It is set to deliver complete visibility of all pharmaceutical products to reduce medicines shortages and fraud, expedite recalls and prevent the sale of expired medicines. Its front-end mobile solution will also provide increased information and transparency for patients. It will offer end-to-end traceability of supplies covering various industry verticals and will be created based on GS1 standards–allowing for a seamless and easy way for manufacturers and supply chain stakeholders outside the UAE to operate. The system will be equipped with the latest state-of-the-art technology and will include SAP products completely based on secure, reliable SAP solution components. “We are trusted by global pharmaceutical companies, including pharmaceutical manufacturers producing COVID vaccines and treatment drugs, as their strategic partner for serialization and traceability compliance. We are honored to partner with EVOTEQ to help Ministry of Health and Prevention’s ‘Tatmeen’ digital initiative to ensure patient safety and a secure supply chain,” said Ross Young, CEO, Movilitas. The post EVOTEQ enters into a partnership agreement with Movilitas appeared first on My Startup World - Everything About the World of Startups!.

EVOTEQ Frequently Asked Questions (FAQ)

  • When was EVOTEQ founded?

    EVOTEQ was founded in 2018.

  • Where is EVOTEQ's headquarters?

    EVOTEQ's headquarters is located at P.O Box 381000, Dubai.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.